BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 30196375)

  • 1. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
    Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
    Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
    PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K; Gut P; Sowińska A; Ruchała M; Fichna M
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS).
    Gielen E; O'Neill T; Pye S; Adams J; Ward K; Wu F; Laurent M; Claessens F; Boonen S; Vanderschueren D; Verschueren S
    Osteoporos Int; 2015 Feb; 26(2):617-27. PubMed ID: 25224294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
    Zhao C; Liu G; Zhang Y; Xu G; Yi X; Liang J; Yang Y; Liang J; Ma C; Ye Y; Yu M; Qu X
    J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
    Li M; Lv F; Zhang Z; Deng W; Li Y; Deng Z; Jiang Y; Wang O; Xing X; Xu L; Xia W
    Osteoporos Int; 2016 May; 27(5):1907-16. PubMed ID: 26733373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.
    Eastell R; Mitlak BH; Wang Y; Hu M; Fitzpatrick LA; Black DM
    Osteoporos Int; 2019 Mar; 30(3):667-673. PubMed ID: 30635696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
    Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN
    Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of adiposity indices with bone density and bone turnover in the Chinese population.
    Wang J; Yan D; Hou X; Chen P; Sun Q; Bao Y; Hu C; Zhang Z; Jia W
    Osteoporos Int; 2017 Sep; 28(9):2645-2652. PubMed ID: 28555285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of daily teriparatide treatment for osteoporosis in men.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2015 Apr; 26(4):1303-9. PubMed ID: 25567777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of bone density in healthy older men with low testosterone levels.
    Kenny AM; Prestwood KM; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.